Sasaki Kazunari, Nair Amit, Firl Daniel J, McVey John C, Moro Amika, Diago Uso Teresa, Fujiki Masato, Aucejo Federico N, Quintini Cristiano, Kwon Choon-Hyuck D, Eghtesad Bijan, Miller Charles M, Hashimoto Koji
Department of General Surgery, Digestive Disease Institute, Cleveland Clinic Lerner College of Medicine, Cleveland Clinic, Cleveland, OH, USA.
Department of Surgery, Duke University Hospital, Durham, NC, USA.
Transpl Int. 2021 Aug;34(8):1433-1443. doi: 10.1111/tri.13846. Epub 2021 Jul 13.
The use of livers from donation after circulatory death (DCD) is historically characterized by increased rates of biliary complications and inferior short-term graft survival (GS) compared to donation after brain death (DBD) allografts. This study aimed to evaluate the dynamic prognostic impact of DCD livers to reveal whether they remain an adverse factor even after patients survive a certain period following liver transplant (LT). This study used 74 961 LT patients including 4065 DCD LT in the scientific registry of transplant recipients from 2002-2017. The actual, 1 and 3-year conditional hazard ratio (HR) of 1-year GS in DCD LT were calculated using a conditional version of Cox regression model. The actual 1-, 3-, and 5-year GS of DCD LT recipients were 83.3%, 73.3%, and 66.3%, which were significantly worse than those of DBD (all P < 0.01). Actual, 1-, and 3-year conditional HR of 1-year GS in DCD compared to DBD livers were 1.87, 1.49, and 1.39, respectively. Graft loss analyses showed that those lost to biliary related complications were significantly higher in the DCD group even 3 years after LT. National registry data demonstrate the protracted higher risks inherent to DCD liver grafts in comparison to their DBD counterparts, despite survival through the early period after LT. These findings underscore the importance of judicious DCD graft selection at individual center level to minimize the risk of long-term biliary complications.
与脑死亡后捐赠(DBD)的同种异体移植物相比,循环死亡后捐赠(DCD)肝脏的使用在历史上的特点是胆道并发症发生率增加,短期移植物存活率(GS)较低。本研究旨在评估DCD肝脏的动态预后影响,以揭示即使在肝移植(LT)后患者存活一定时期后,DCD肝脏是否仍然是一个不利因素。本研究使用了2002年至2017年移植受者科学登记处的74961例LT患者,其中包括4065例DCD LT。使用Cox回归模型的条件版本计算DCD LT中1年GS的实际、1年和3年条件风险比(HR)。DCD LT受者的实际1年、3年和5年GS分别为83.3%、73.3%和66.3%,明显低于DBD受者(所有P<0.01)。与DBD肝脏相比,DCD中1年GS的实际、1年和3年条件HR分别为1.87、1.49和1.39。移植物丢失分析表明,即使在LT后3年,DCD组因胆道相关并发症而丢失的患者也明显更多。国家登记数据表明,与DBD肝脏相比,DCD肝移植长期存在更高的固有风险,尽管在LT后的早期能够存活。这些发现强调了在个体中心层面明智选择DCD移植物以尽量降低长期胆道并发症风险的重要性。